Phytochemicals for the treatment of COVID-19.
J Microbiol
; 59(11): 959-977, 2021 Nov.
Article
in English
| MEDLINE | ID: covidwho-1491414
ABSTRACT
The coronavirus disease 2019 (COVID-19) pandemic has underscored the lack of approved drugs against acute viral diseases. Plants are considered inexhaustible sources of drugs for several diseases and clinical conditions, but plant-derived compounds have seen little success in the field of antivirals. Here, we present the case for the use of compounds from vascular plants, including alkaloids, flavonoids, polyphenols, and tannins, as antivirals, particularly for the treatment of COVID-19. We review current evidence for the use of these phytochemicals against SARS-CoV-2 infection and present their potential targets in the SARS-CoV-2 replication cycle.
Keywords
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Main subject:
Antiviral Agents
/
Pandemics
/
Phytochemicals
/
SARS-CoV-2
/
COVID-19 Drug Treatment
Type of study:
Prognostic study
Limits:
Animals
/
Humans
Language:
English
Journal:
J Microbiol
Journal subject:
Microbiology
Year:
2021
Document Type:
Article
Similar
MEDLINE
...
LILACS
LIS